Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-09-21
1995-06-27
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548131, 546277, C07D27106, A61K 3141
Patent
active
054280478
ABSTRACT:
The present invention relates to the use of substituted 1,2,4-oxadiazole derivatives of the general formula I ##STR1## in which R.sup.1 represents hydrogen, alkyl which is optionally substituted by halogen, alkoxy, hydroxyl, amino, alkylamino, dialkylamino, cycloalkylamino as well as cycloalkyl, optionally substituted aryl or hetaryl,
REFERENCES:
patent: 3879407 (1975-04-01), Hagarty
patent: 4012377 (1977-03-01), Claisse et al.
patent: 4294842 (1981-10-01), Weston
patent: 4294843 (1981-10-01), Weston
patent: 4488895 (1984-12-01), Stetler
J. Chem. Soc. (1971), D. J. Brown, B. T. England: "The Dimroth Rearrangement".
A. R. Katritzky/C. W. Rees in "Comprehensive Heterocyclic Chemistry", Pergamon Press, Oxford/New York, 1984, vol. 3, pp. 93-98.
J. Heterocycl. Chem. 16 (1979) pp. 1469-1475.
Derwent abstract 93-073855/09 (1990).
Derwent abstract 92-062062/08 (1990).
Derwent abstract 92-185001/23 (1990).
Chemical abstract 98:198238y, "Ethyloxadiazole derivatives" (1983).
Chemical Abstracts, vol. 110, No. 19, 1989, Abstract No. 173224u, p. 776.
Chemical Abstracts, vol. 98, No. 23, 1983, Abstract No. 198238y, p. 657.
Harder Achim
Jeschke Peter
Lindner Werner
Mencke Norbert
Bayer Aktiengesellschaft
Gerstl Robert
LandOfFree
Use of substituted 1,2,4-oxadiazole derivatives for combating en does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of substituted 1,2,4-oxadiazole derivatives for combating en, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of substituted 1,2,4-oxadiazole derivatives for combating en will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287821